Professional Documents
Culture Documents
2018 Clinical Practice Guidelines: Foot Care
2018 Clinical Practice Guidelines: Foot Care
For permission to use this slide deck for commercial or any use
other than personal, please contact guidelines@diabetes.ca
2018 Diabetes Canada CPG – Chapter 32. Foot Care
2018
Key Changes
• New information on
L
• Detailed instructions on use of theY 10 gram
ONpresence or
monofilament to screen forEthe
US
absence of protective sensation
L
NA
O
RS
PE
L Y
ON
SE
L U
NA
SO
R
PE
Public Health Agency of Canada (August 2011); using 2008/09 data from the Canadian Chronic Disease Surveillance System (Public Health Agency of Canada).
L Y
Check the colour of your legs & feet – seek help if there is swelling, warmth or redness
Wash and dry your feet every day, especially betweenO
N
S E the toes
Cut your own corns or callouses, nor treat your own in-growing toenails or slivers with a
razor or scissors. See your doctor or foot care specialist
L Y
Use over-the-counter medications to treat corns and warts
O N
Apply heat with a hot water bottle or electric blanket E
U S – may cause burns unknowingly
A
Soak your feet or use lotion between your toes L
O N
Take very hot baths
R S
P
Walk barefoot inside or outside E
Wear tight socks, garter or elastics or knee highs
Wear over-the-counter insoles – may cause blisters if not right for your feet
Sit for long periods of time
Smoke
Element Parameter
Inspection • Gait
• Foot morphology (Charcot arthropathy, bony prominences)
•
Y
Toe morphology (clawtoe, hammertoe, number of toes)
• L
Skin: blisters, abrasions, calluses, subkeratotic hematomas
N
O
or hemorrhage, ulcers, absence of hair, toe nail problems,
E
edema, abnormal color
• Status of nails U S
AL
• Foot hygiene (cleanliness, tinea pedis)
O N
R S
Palpation •
•
E
P (increased or decreased warmth)
Pedal pulses
Temperature
Protective • Sensation to 10 gram monofilament
sensation
Footwear • Exterior: signs of wear, penetrating objects
• Interior: signs of wear, orthotics, foreign bodies
Modified from: Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K; International Working Group on
the Diabetic Foot. Prevention and management of foot problems in diabetes: A Summary Guidance for
Daily Practice 2015, based on IWGDF Guidance Documents. Diabetes Metab Res Rev 2016;32 PERSONAL
Suppl 1:7-15
USE ONLY
Screening for Protective Sensation Using
The 10 gram Monofilament
Apply the monofilament B Apply sufficient force to cause the
A perpendicular to the skin surface filament to bend or buckle
L Y
ON
SE
L U
NA
SO
E R
P
How to Apply the monofilament:
• Repeat the application twice at the same site, but alternate the application with
at least one ‘mock’ application in which no filament is applied (total three
questions per site).
• Protective sensation is present at each site if the patient correctly answers two
out of three applications. Incorrect answers – the patient is then considered to
lack protective sensation and is at risk of foot ulceration.
Modified from: Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K; International Working Group on
the Diabetic Foot. Prevention and management of foot problems in diabetes: A Summary Guidance for
Daily Practice 2015, based on IWGDF Guidance Documents. Diabetes Metab Res Rev 2016;32 PERSONAL
Suppl 1:7-15
USE ONLY
2018 Diabetes Canada CPG – Chapter 32. Foot Care
Low Risk LY
• Annually
O N
SE
U
L • More frequent
High risk
NA
for ulcer SO e.g. Every 3-6 months
R
PE
Foot ulcer • Refer to an
present interprofessional team
with expertise in foot
ulcers
epithelialized SO
ischemia) completely tendon, capsule, to tendon to bone or
R or bone or capsule joint
PE
B Infection Infection Infection Infection
C Ischemia Ischemia Ischemia Ischemia
D Infection and Infection and Infection Infection
ischemia ischemia and and
ischemia ischemia
Recommendation 1
1. Health-care providers should perform foot
examinations to identify people with diabetes at risk for
ulcers and lower-extremity amputation
L Y [Grade C, Level 3] at
least annually and at more frequent O N intervals in high-
S
risk people [Grade D, Level 4]. TheEexamination should
include assessment for:AL
U
• Neuropathy, O N
R S
• Skin changes E
P (e.g., calluses, ulcers, infection),
• Peripheral arterial disease (e.g., pedal pulses and
skin temperature),
• Structural abnormalities (e.g., range of motion of
ankles and toe joints, bony deformities) [Grade D,
Level 4]
2018
Recommendation 2
2. People with diabetes who are at high risk of
developing foot ulcers should receive foot care
education (including counselingN toLY
avoid foot
E O footwear [Grade
trauma) and professionallySfitted
D, Consensus]. L U
N A early referral to a health-
2
SO
• When foot complications occur,
R
PE
care professional trained in foot care is recommended [Grade
C, Level 3]
Recommendation 3
3. People with diabetes who develop a foot ulcer or
show signs of infection even in the absence of
pain should be treated promptly L Y an
by
O N
interprofessional health-care SE team (when
available) with expertiseLinUthe treatment of foot
N A foot ulcers and
ulcers to prevent recurrent
SO
ER C, Level 3]
amputation [Grade
P
Recommendation 4
4. There is insufficient evidence to recommend any
specific dressing type for typical diabetic foot
ulcers [Grade C, Level 3]. L Y
N O A, Level 1A] and
• Debridement of nonviable tissueE[Grade
USinclude the provision of a
general principles of woundLcare
NA environment, and off-
physiologically moist wound
SOD, Consensus]
loading the ulcer [Grade
R
PE
Recommendation 5
5. There is insufficient evidence to recommend the
routine use of adjunctive wound-healing
L
therapies (eg. topical growth factors,Y granulocyte
ON
colony-stimulating factors, orSEdermal substitutes),
LU
for typical diabetic foot ulcers.
A
• Provided that all otherO N
modifiable factors (e.g. pressure
R S foot deformity etc) have been
P E
offloading, infection,
addressed, adjunctive wound-healing therapies may be
considered for non-healing, non-ischemic wounds [Grade A,
Level 1].
Key Messages
• In persons with diabetes, lower extremity
complications are a major cause of Y morbidity
and mortality N L
EO
U S
• The treatment of foot ulcers in people who
L
A a interprofessional
N
have diabetes requires
O
R S
approach that addresses glycemic control,
PE
infection, off-loading of high-pressure areas,
lower-extremity vascular status, and local
wound care
Key Messages
• Antibiotic therapy is not required for
LY
uninfected neuropathic footNulcers
E O
• Proprietary adjunctive Swound dressings
L U
and technologies N A
including antimicrobial
dressings lack R SO
sufficient evidence to
PE
support their routine use in the treatment of
neuropathic ulcers
L Y
ON
SE
L U
NA
SO
R
PE
L Y
ON
SE
L U
NA
SO
R
PE
L Y
www.guidelines.diabetes
.caE O
N
U– Sfor health-care
AL providers
O N
R S
PE 1-800-BANTING (226-
8464)
www.diabetes.ca – for
people with diabetes